HG2

General Information


DRACP ID  DRACP04517

Peptide Name   HG2

Sequence  MKKLLLILFCLALALAGCKKAP

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C111H196N26O23S3

Absent amino acids  DEHNQRSTVWY

Common amino acids  L

Mass  273392

Pl  10.35

Basic residues  4

Acidic residues  0

Hydrophobic residues  13

Net charge  4

Boman Index  3323

Hydrophobicity  138.18

Aliphatic Index  160

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  5.95

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35835775

Title  In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20288

DRACP is developed by Dr.Zheng's team.